Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Lancet. Oncology
|
October 11, 2011
NICE guidance on bortezomib and thalidomide for first-line treatment of multiple myeloma
Sally Doss, Nicola Hay, Frances Sutcliffe
The Lancet. Oncology
|
October 2, 2012
Lapatinib or trastuzumab in combination with an aromatase inhibitor for first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2
Sally Doss, Janet Robertson, Jane Adam
The Lancet. Oncology
|
March 10, 2012
NICE guidance on rituximab for first-line treatment of symptomatic stage III-IV follicular lymphoma in previously untreated patients
Sally Doss, Zoe Garrett, Frances Sutcliffe, et al.
The Lancet. Oncology
|
December 26, 2015
NICE guidance on trastuzumab emtansine for HER2-positive advanced breast cancer
Ahmed Elsada, Sally Doss, Janet Robertson, et al.
The Lancet. Oncology
|
October 21, 2014
NICE guidance on ipilimumab for treating previously untreated advanced (unresectable or metastatic) melanoma
Caroline J Hall, Sally Doss, Janet Robertson, et al.
The Lancet. Oncology
|
February 1, 2016
NICE guidance on panobinostat for patients with multiple myeloma after at least two previous treatments
Caroline J Hall, Sally Doss, Nicola Hay, et al.
The Lancet. Neurology
|
October 7, 2014
Alemtuzumab for relapsing-remitting multiple sclerosis
Richard A Diaz, Sally Doss, Martyn J Burke, et al.
Dermatology Practical & Conceptual
|
August 7, 2019
Scalp Pemphigus Vulgaris Mimicking Folliculitis Decalvans: A Case Report
Manal Bosseila, Eman A Nabarawy, Mostafa A Latif, et al.
International Journal of Dermatology
|
March 7, 2019
Lichenoid papules in the periorbital area
Galal El-Enany, Marwa M Fawzy, Mona R E Abdel-Halim, et al.
Cutis
|
May 23, 2019
Unilateral facial papules and plaques
Mona Re Abdel-Halim, Marwa Fawzy, Marwah A Saleh, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Lancet. Oncology
|
October 11, 2011
NICE guidance on bortezomib and thalidomide for first-line treatment of multiple myeloma
Sally Doss, Nicola Hay, Frances Sutcliffe
The Lancet. Oncology
|
October 2, 2012
Lapatinib or trastuzumab in combination with an aromatase inhibitor for first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2
Sally Doss, Janet Robertson, Jane Adam
The Lancet. Oncology
|
March 10, 2012
NICE guidance on rituximab for first-line treatment of symptomatic stage III-IV follicular lymphoma in previously untreated patients
Sally Doss, Zoe Garrett, Frances Sutcliffe, et al.
The Lancet. Oncology
|
December 26, 2015
NICE guidance on trastuzumab emtansine for HER2-positive advanced breast cancer
Ahmed Elsada, Sally Doss, Janet Robertson, et al.
The Lancet. Oncology
|
October 21, 2014
NICE guidance on ipilimumab for treating previously untreated advanced (unresectable or metastatic) melanoma
Caroline J Hall, Sally Doss, Janet Robertson, et al.
The Lancet. Oncology
|
February 1, 2016
NICE guidance on panobinostat for patients with multiple myeloma after at least two previous treatments
Caroline J Hall, Sally Doss, Nicola Hay, et al.
The Lancet. Neurology
|
October 7, 2014
Alemtuzumab for relapsing-remitting multiple sclerosis
Richard A Diaz, Sally Doss, Martyn J Burke, et al.
Dermatology Practical & Conceptual
|
August 7, 2019
Scalp Pemphigus Vulgaris Mimicking Folliculitis Decalvans: A Case Report
Manal Bosseila, Eman A Nabarawy, Mostafa A Latif, et al.
International Journal of Dermatology
|
March 7, 2019
Lichenoid papules in the periorbital area
Galal El-Enany, Marwa M Fawzy, Mona R E Abdel-Halim, et al.
Cutis
|
May 23, 2019
Unilateral facial papules and plaques
Mona Re Abdel-Halim, Marwa Fawzy, Marwah A Saleh, et al.
Page
of 1